Outcomes Following Macrolide Use in Kidney Transplant Recipients
Outcomes Following Macrolide Use in Kidney Transplant Recipients
About this item
Full title
Author / Creator
Publisher
Los Angeles, CA: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
Los Angeles, CA: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background:
Calcineurin inhibitors (CNI; cyclosporine, tacrolimus) are critical for kidney transplant immunosuppression, but have multiple potential drug interactions, such as with macrolide antibiotics. Macrolide antibiotics (clarithromycin, erythromycin, and azithromycin) are often used to treat atypical infections. Clarithromycin and erythrom...
Alternative Titles
Full title
Outcomes Following Macrolide Use in Kidney Transplant Recipients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_82e76dc0f4ac4f43bce3f80cd8476ef9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82e76dc0f4ac4f43bce3f80cd8476ef9
Other Identifiers
ISSN
2054-3581
E-ISSN
2054-3581
DOI
10.1177/2054358119830706
